NEW YORK (GenomeWeb News) – Pharmaceutical software company Simulations Plus said on Thursday that the National Institutes of Health has renewed a license agreement for the company’s cheminformatics screening platform.
The Lancaster, Calif.-based company said that the NIH has renewed five licenses for the company’s ClassPharmer software, which it will use in its Chemical Genomics program.
The licenses were originally struck in August of 2007, and have now been renewed for another year.
The ClassPharmer software includes data analysis features for intuitive class generation, querying and similarity screening, data visualization and filtering, and other functions.
Financial terms of the agreement were not released.